CYNTHIA SHIELDS: Open Payments
NPI 1588098057 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$260 in 13 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $76 · 2025 $260
Food & beverage: $260
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 2 | $29 |
| ABBVIE INC. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Exelixis Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
Products named: ELREXFIO, ICLUSIG, KISQALI, IMBRUVICA, ENHERTU, LYNPARZA, CABOMETYX, VERZENIO.
Industry payments across FL — which companies pay providers there.
